Dustin Hines

Associate Professor, Department of Psychology
Expertise: Neuroscience, Human behavior, Nervous system, Alzheimer's disease, Traumatic brain injury, Stroke, Molecular genetics, Biochemistry

Biography

Dustin Hines is an associate professor of neuroscience in 51³Ô¹ÏÍøÍòÄÜ¿Æ´ó's psychology department. His expertise focuses on understanding brain function, how its cells interact to influence behavior, and supportive mechanisms within the central and peripheral nervous systems.

Hines is a co-director of the Hines Group Comprehensive Neuroscience Lab, which has pioneered the study of non-neuronal cells, known as glial cells, in the processing of information for behavioral output. His research has examined the role that glial cells play under normal and abnormal conditions, which include neuropsychiatric disorders (such as depression and PTSD), traumatic brain injury, stroke, and Alzheimer's disease. Other studies have investigated the roles of astrocytes in complex behaviors such as cognition and attention, as well as in sleep disorders and other conditions. Most recently, the lab has delved into the possible medical benefits of psychedelics.

In addition to research and teaching, Hines mentors and oversees research by high school, undergraduate, graduate, and postdoctoral students. In 2021, his lab received funding from the National Institutes of Health for an initiative to improve collaborative biomedical research efforts in the American West. 

Education

  • Postdoctoral Fellowship, Tufts University School of Medicine
  • Ph.D., Neuroscience, University of British Columbia

Dustin Hines In The News

MDLinx
The US Drug Enforcement Administration (DEA) plans to reclassify marijuana to a Schedule III controlled substance from Schedule I. This shift would not only recognize the drug’s medicinal uses, but also acknowledge that it has less potential for abuse.
51³Ô¹ÏÍøÃâ·ÑApp Review Journal
While most psychedelic drugs remain illegal, that could change as their health benefits become more widely known both in the United States and Nevada, where further psychedelic-assisted therapy could be on the horizon.
M.S.N.
An estimated 11% of adults in the US said in a 2021 survey they had taken psilocybin or mushrooms. But not everyone makes "magic mushrooms" a family affair.
Yahoo!
Neuroscientists explain how developing brains may be vulnerable to psilocybin's negative effects.

Articles Featuring Dustin Hines

Remember sculptor Claes Oldenburg who created U.N.L.V.'s iconic Flashlight sculpture this month.
Campus News | August 3, 2022

A collection of news stories highlighting university experts’ insights on and contributions to health, environment, and society.

April Contreras stands behind cacti.
People | March 31, 2022

Neuroscience Ph.D. student April Contreras is set to share her research on psychedelics and psychiatry at this year’s Inspiration, Innovation, Impact event